The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.
Category: Coronavirus Omicron Variant
-
Covid Vaccines May Roll Out Within Days
The F.D.A. is expected to approve a new round of shots by Pfizer and Moderna as early as Monday to prepare Americans for the fall and winter season when infections usually tick upward.
-
FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant
An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.
-
F.D.A. Outlines a Plan for Annual Covid Boosters
In advance of a scientific meeting on Thursday, officials proposed offering new shots to Americans each fall, a strategy long employed against the flu.
-
How Bad Is China’s Covid Outbreak? It’s a Scientific Guessing Game.
In the absence of credible information from the Chinese government, researchers around the world are looking for any clues to determine the size and severity of the surge.
-
China Eases ‘Zero Covid’ Restrictions in Victory for Protesters
Beijing’s costly policy of lockdowns has pummeled the world’s second-largest economy and set off mass public protests that were a rare challenge to China’s leader, Xi Jinping.
-
Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
The shots may help older, pregnant and immunocompromised Americans dodge serious illness or death. But the doses are not likely to prevent infections in any group, recent studies suggest.